Brain implants to repair Parkinson’s damage being developed by University of Cambridge researchers
Brain implants that could help repair the pathways damaged by Parkinson’s disease are being developed by University of ...
Inhibikase Therapeutics, Inc. (IKT), a biopharmaceutical company with a market capitalization of $189.48 million, has announced the halting of further development of its Parkinson's disease drug, ...
Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...
A pathway once considered fundamental in Alzheimer’s disease is being studied intensely again, and may soon result in safer, ...
The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...
Parkinson’s disease is a progressive neurodegenerative disorder that affects millions of people worldwide. In the United ...
New research reveals a significant reduction in Parkinson’s disease risk among autoimmune patients treated with anti-TNF or ...
Anavex’s newest patent will be expected to remain in force at least until July 2039, not including any patent term extensions. It will expand and supplement the current ANAVEX®2-73 (blarcamesine) ...
The findings revealed a potential link between the use of these drugs and an increased risk of Parkinson’s disease. The risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback